Evidence remains limited regarding diagnostic criteria and recommendations for the treatment of lipodystrophy in children, in part due to the rarity of the syndrome, according to a systematic review ...
The lipodystrophies can be divided into generalized, partial or local, depending on the degree and locality of the observable fat loss; moreover, the generalized and partial divisions can be ...
The US Food and Drug Administration (FDA) has approved Amylin Pharmaceuticals' Myalept (metreleptin for injection) as replacement therapy to treat the complications of leptin deficiency, in addition ...
Lipodystrophy is a collective term used to describe a bunch of heterogeneous conditions associated with body fat and predisposition to metabolic illnesses such as ...
Too much body fat is generally bad for our cardiovascular system, and now scientists are learning more about how too little fat yields some of the same damage. AUGUSTA, Ga. (Oct. 16, 2017) - We know ...
Lipodystrophy is a fat metabolism error, which manifests clinically in the form of excessive fat deposition in some areas such as the abdomen, the back, face and neck, or the breasts, or simply as ...
As an adjunct to diet, MYALEPTA is indicated as a replacement therapy to treat the complications of leptin deficiency in lipodystrophy (LD) patients with confirmed congenital generalised LD ...
With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback